CHESTAsthma

Asthma

In brief: what’s new and notable in asthma

Explore new and notable updates in asthma, including research into the effects of treatment with D2 receptor antagonists in severe eosinophilic asthma, a study exploring the long-term impact of dupilumab, and a quick-hit Twitter program reviewing clinical concepts for severe asthma. Review an infographic about asthma and COVID-19, test your clinical expertise with the Asthma Ascent game in the Player Hub, and read the latest from the CHEST Networks in the CHEST Physician® publication.

Must-reads and more in CHEST® journal

CHEST Journal image
ORIGINAL RESEARCH

Results of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma

Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial

Azithromycin for Poorly Controlled Asthma in Children: A Randomized Controlled Trial

The Relationship Between Insurance Status and the Affordable Care Act on Asthma Outcomes Among Low-Income US Adults

Genetic Associations and Architecture of Asthma-COPD Overlap

Does Dupilumab Sustain Oral Corticosteroid (OCS) Reduction in Patients With Corticosteroid-Dependent Asthma?
VISUAL ABSTRACT

This visual abstract compares the results of a study exploring the long-term effects of treatment with dupilumab on oral corticosteroid use in patients with corticosteroid-dependent asthma.

VIEW THE DOWNLOADABLE PDF

READ THE RELATED ARTICLE »

CHEST Journal | Access even more asthma research in this month’s issue. READ THE JOURNAL »

On this page

RESOURCES

Severe asthma program

Gender differences in asthma

NEWS

Shared decision-making tool

EDUCATION

Difficult Airway Management

Advertisement

Laptop image

Patient education resources to share

The asthma experience is not gender neutral. Women and girls are more likely to have asthma, their asthma may be more severe, and they are at greater risk for poor outcomes. The Women with Asthma section, now available from the CHEST Foundation, details the unique aspects of asthma in this population.

Learn more about how female biology affects the prevalence and severity of asthma symptoms; risk factors for severe asthma in women and girls; and how menstruation, pregnancy, and menopause can affect asthma exacerbations.

LEARN MORE ABOUT WOMEN WITH ASTHMA »

Laptop image

Advertisement

 

Asthma news and notes

Follow the latest asthma news

AIRWAYS DISORDERS NETWORK

Go TEAM! Shared decision-making tool for patient-clinician collaboration in severe asthma
Read tips and tools to improve patient-clinician collaboration in the treatment and management of severe asthma.

DEEP BREATHS: UPDATES FROM CHEST

Meeting the Needs of Uncontrolled Asthma Patients
This podcast explores ways clinicians can better recognize and treat patients with uncontrolled or symptomatic asthma.

PULMONARY PERSPECTIVES®

Updates on eosinophilia in asthma
Review the latest data on eosinophilia in patients with mild to moderate asthma, including the utility of blood eosinophil levels in predicting outcomes for these patients.

DEEP BREATHS: UPDATES FROM CHEST

Investigating T2 Inflammation in Severe Asthma & COPD
Type 2 (T2) inflammation can be challenging to identify. This podcast covers what clinicians should be looking for in patients with severe asthma to identify T2 inflammation.

CHEST PHYSICIAN

NIAID trial to test asthma drug in disadvantaged urban children
Learn more about the recently launched Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents (PANDA) trial.

DEEP BREATHS: UPDATES FROM CHEST

Closing the Gaps in Care: A Look at Diagnostic Challenges for Severe Asthma
Review diagnostic challenges in severe eosinophilic asthma with this podcast.

Join the Community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.

JOIN NOW »